Clinical Trials
4
Active:0
Completed:1
Trial Phases
2 Phases
Phase 2:2
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 4
1 (33.3%)Characterization of Human Cancers by Molecular Profiling of Patient Biospecimens
- Conditions
- Cancer
- First Posted Date
- 2016-04-25
- Last Posted Date
- 2016-04-25
- Lead Sponsor
- Pharmatech
- Target Recruit Count
- 183
- Registration Number
- NCT02749838
- Locations
- 🇺🇸
Pharmatech Inc., Denver, Colorado, United States
Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer
- First Posted Date
- 2016-04-25
- Last Posted Date
- 2016-04-25
- Lead Sponsor
- Pharmatech
- Target Recruit Count
- 41
- Registration Number
- NCT02749825
- Locations
- 🇺🇸
Arizona Urologic Specialists, Tucson, Arizona, United States
🇺🇸Heritage Physician Group - Urology Department, Hot Springs, Arkansas, United States
🇺🇸California Oncology of the Central Valley, Fresno, California, United States
Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Phase 2
Completed
- Conditions
- Diffuse Large B-Cell Lymphoma
- Interventions
- First Posted Date
- 2009-01-29
- Last Posted Date
- 2016-04-19
- Lead Sponsor
- Pharmatech
- Target Recruit Count
- 61
- Registration Number
- NCT00831597
- Locations
- 🇺🇸
Pharmatech Oncology Study Site, Richardson, Texas, United States
Phase II Avastin Trial for Stage IIIB/IV NSCLC
Phase 2
Terminated
- Conditions
- Non-small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IV
- Interventions
- First Posted Date
- 2008-10-03
- Last Posted Date
- 2016-04-19
- Lead Sponsor
- Pharmatech
- Target Recruit Count
- 125
- Registration Number
- NCT00766246
News
No news found